Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. crawled time : 23:00 save search
Update: Annual Changes to the Nasdaq-100® Index
Published: 2023-12-12 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: -8.05%
H: 1.71%
C: 1.45%
TTWO 4 | $140.345 -0.21% 1.3M
|
Consumer Durables
|
| O: 2.51%
H: 1.8%
C: 1.23%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.03%
H: 0.01%
C: -0.08%
NDAQ | $60.16 0.15% 1.9M
|
Finance
|
| O: 0.11%
H: 4.08%
C: 3.98%
100 index
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published: 2023-10-24 (Crawled : 23:00) - prnewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.1%
H: 1.77%
C: 0.89%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: 2.75%
H: 0.46%
C: -1.76%
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: -0.18%
H: 1.34%
C: 1.05%
PTCT | $25.14 1.82% 650K
|
Health Technology
|
| O: -1.34%
H: 2.23%
C: 1.62%
LXRX | News | $1.655 1.53% 1.6M
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -2.99%
expansion global duchenne market
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published: 2023-10-04 (Crawled : 23:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.59%
H: 0.29%
C: 0.22%
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.42%
H: 0.99%
C: 0.06%
SCYX | $1.45 3.2% 100K
|
Health Technology
|
| O: 0.45%
H: 4.04%
C: 0.45%
CDTX | $0.714 -1.11% 240K
|
Health Technology
|
| O: 0.39%
H: 10.33%
C: 3.9%
report treatment candidiasis research global growing market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.735 -0.11% 620K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
| Email alert
Add to watchlist
NBIX M | $130.31 -1.68% 260K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $63.676 7.2K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $126.05 100
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 800
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.91 2.05% 22M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.19 0.23% 740K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.285 1.85% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.89 1.22% 5.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.41 0.07% 2.9M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | $727.48 -2.48% 2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
Published: 2023-02-10 (Crawled : 23:00) - biospace.com/
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.37%
H: 1.1%
C: 0.87%
cibinqo fda drug application
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: -0.28%
H: 0.19%
C: -0.44%
results
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $87.13 1.11% 350K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | $87.13 1.11% 350K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Published: 2021-07-08 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.71%
H: 1.44%
C: 0.2%
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: -0.04%
H: 0.88%
C: 0.24%
BIIB | $193.75 1.7% 1M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
disease genetic collaboration rare
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
Published: 2021-06-30 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.03%
H: 1.17%
C: 1.0%
SPRO | $1.455 -1.02% 210K
|
Health Technology
|
| O: 19.27%
H: 2.94%
C: -1.56%
license
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Published: 2021-06-16 (Crawled : 23:00) - biospace.com/
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.08%
H: 0.56%
C: -0.81%
covid brazil
Insights on the Meningococcal Vaccine Global Market to 2026 - Featuring GlaxoSmithKline, Pfizer and Sanofi Among Others
Published: 2021-04-20 (Crawled : 23:00) - prnewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.28%
H: 1.35%
C: 1.0%
GSK | $39.585 0.8% 1.1M
|
Health Technology
|
| O: 0.72%
H: 0.93%
C: 0.74%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.4%
vaccine
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
Published: 2021-02-17 (Crawled : 23:00) - globenewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: -0.32%
H: 0.28%
C: -0.63%
BNTX | $87.13 1.11% 350K
|
Health Technology
|
| O: -4.9%
H: 5.19%
C: 4.31%
covid vaccine sars-cov-2 in vitro
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Published: 2020-12-28 (Crawled : 23:00) - biospace.com/
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: 0.24%
H: 0.59%
C: -1.45%
positive cancer fda lung cancer
Gainers vs Losers
| 70% | 30% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.